Transcriptional analysis and genome expression of chicken anaemia virus
Strand-specific riboprobes representative of either strand of the chicken anaemia virus (CAV) replicative form (RF) DNA indicated that only one strand of the RF was transcribed to produce a major 2.0 kb transcript and that the encapsidated DNA strand was of negative sense. Primer extension analysis located a single transcriptional start site at nucleotide position 360 of the CAV sequence. Amplification, cloning and sequencing of the 3' end of the major transcript revealed the polyadenylation site at nucleotide position 21. Northern blot analysis using a series of genomic probes indicated that the 2.0 kb transcript was devoid of splicing and identified a non-transcribed region of the genome. This nontranscribed region was shown to possess promoter activity, enhancing the expression of the human growth hormone reporter gene in a transient gene expression assay. These observations suggest a simple strategy of genome expression involving a functional polycistronic message.
Chicken anaemia virus (CAV) causes clinical and subclinical disease in chickens and is recognized as an important avian pathogen worldwide (McNulty, 1991) . The virus has been characterized as a small icosahedral non-enveloped particle (23 to 25 nm in diameter) containing a 2.3 kb circular, ssDNA genome (Gelderblom et al., 1989; McNulty et al., 1990; Noteborn et al., 1991 ; Todd et al., 1990) . A single structural protein (M r 50K) has been identified in purified virus particles . It has been proposed that CAV be assigned to the new virus family, Circoviridae, along with two other small ssDNA animal viruses (Studdert, 1993) , porcine circovirus (PCV) and psittacine beak and feather disease virus. A circular, double-stranded replicative form (RF) of CAV DNA has been isolated, cloned, sequenced and shown by transfection to contain all the elements required to produce infectious virus (Noteborn et al., 1991; Meehan et al., 1992) . Sequence analysis indicated that the three partially overlapping open reading frames (ORFs) encoding potential proteins of M r 52K, 24K and 13K, together with appropriately positioned transcription initiation and termination signals, could be identified on one of the two strands constituting the RF. In addition, a putative non-coding region rich in transcription regulatory sequences has been located upstream of the three major ORFs (Claessens et al., 1991 ; Meehan et al., 1992; Noteborn et al., 1991) .
In this paper, we report the characterization and mapping of the CAV-specific RNA species and demonstrate promoter activity associated with the nontranscribed region of the genome.
The Cux-1 isolate of CAV (von Biilow et al., 1983) , was grown in the Marek's disease virus-transformed chicken lymphoblastoid MDCC-MSB1 cell line as described previously (McNulty et al., 1988) . Total RNA was isolated from infected cells harvested at 12, 24, 36, 48 and 72h post-infection (p.i.) by the guanidinium isothiocyanate/CsC1 method and analysed on a 1% denaturing formaldehyde gel (Sambrook et al., 1989) . Virus-specific RNA was identified as early as 12 h p.i. and was shown to increase to a maximum level at 48 h p.i. (data not shown). Subsequent purification of poly(A) mRNA was performed by affinity chromatography using oligo(dT)-cellulose (Pharmacia). A major 2"0 kb transcript together with a minor transcript of approximately 4-0kb was detected using a random-primed probe prepared from cloned CAV DNA (Todd et al., 1991) and sized using RNA markers (Promega; Fig. 1 a) . These transcripts were absent from extracts of uninfected MDCC-MSB1 cells and at no time during infection was there any evidence of smaller transcripts (data not shown). Resistance to DNase treatment (data not shown) and its presence in poly(A)-selected preparations support the view that the 4.0 kb RNA is a virus-specific transcript which may occur if a small proportion of the RNA polymerase molecules fail to terminate transcription efficiently on the circular DNA genome. It is likely that termination of transcription occurs within the region of extreme RNA secondary structure located downstream of the termination codon of the M r 52K ORF (Claessens et al., 1991) .
Strand-specific riboprobes were used to determine the polarity of the encapsidated DNA. The complete 2-3 kb lanes 6 to 10, as lanes 1 to 5 above, using probe T7-1.
genome was cloned into the EcoRI site of pBluescript IIKS + / -(Stratagene) in both orientations with respect to the T7 promoter. Templates were linearized downstream of the insert by digestion with XhoI and treated with proteinase K at 50 gg/ml (Promega). In vitro transcription reactions using T7 polymerase were performed with 2 gg of template in a 50 I.tl volume of 40 mNTris-HC1 pH 7"5, 6 mM-MgC]~, 2 m~-spermidine, 10 mM-NaCI and 2-5 mM of each rNTP, for 90 min at 28 °C, followed by treatment with DNAse. Radiolabelled riboprobes were generated by the inclusion of [32P]rUTP SSC/0"1% SDS at 70 °C). The strand specificity of each probe was confirmed by hybridizing probes T7-1 and T7-2 to their corresponding unlabelled in vitro transcripts blotted onto nitrocellulose filters. Probe T7-1 hybridized only to ssDNA whereas the T7-2 probe hybridized specifically to viral RNA (Fig. 1 c) . This confirms that only one of the two strands of the RF is transcribed to produce m R N A and that the encapsidated DNA strand is of negative sense (Noteborn et al., 1991) . A primer extension assay was performed to locate the 5' start site of the major 2.0 kb transcript. An oligonucleotide primer (5' TCTCGGCTAAGCGCCGATT-CACTG 3'), which was complementary to a region approximately 100 nucleotides (nt) downstream from the putative cap site (Noteborn et al., 1991) , was 5' endlabelled with 32p using T4 polynucleotide kinase, annealed to 50 gg of total RNA and extended with reverse transcriptase (Sambrook et al., 1989) . Primer extension products were fractionated on a denaturing 6% polyacrylamide/8 M-urea gel and a nt sequencing ladder of cloned CAV DNA, initiated using the same primer, was included for comparative purposes. Sequencing was performed using the CircumVent Thermal Cycle DNA Sequencing Kit (New England Biolabs). A single product (Fig. 2 a) was located at nt position 360 (A residue) of the CAV sequence. In agreement with Noteborn et al. (1992) , this places the 5' end of the major transcript 30 nt downstream of the TATA box at nt positions 329 to 325, and 25 nt upstream from the initiation codon of the first major ORF at nt positions 386 to 388 of the CAV sequence (Meehan et at., 1992) .
Sequence analysis of the CAV genome identified a unique poly(A) addition signal (AAUAAA) downstream of the three long ORFs at nt positions 2293 to 2298 (Meehan et al., 1992 ). The precise location of the 3' terminus of the transcript was determined by rapid amplification of 3' cDNA ends, as described by Frohman et al. (1988) . Briefly, total RNA (2 ~tg) extracted from infected and uninfected MDCC-MSB1 cells was independently subjected to cDNA synthesis initiated with a hybrid d(T)l 7 adapter primer [5' GGAATTCTGCAG-GATCC(T)17 3']. Resultant cDNAs were amplified by a conventional DNA PCR protocol (94 °C for 1 min; 56 °C for 2 min; 72 °C for 3 min) using a CAV-specific primer (5' G C T C T A G A G G A G C C G G G G A C 3') and the adapter primer. The amplified DNA product of approximately 450 bp was cloned into the E c o R I and XbaI sites of pBluescript IIKS + / -(Stratagene). The immediate 3' end of the transcript was then sequenced as before using the M I 3 ( -2 4 ) reverse sequencing primer (Stratagene). Sequence information from six clones indicated that the polyadenylation site was located 21 nt downstream from the poly(A) addition signal, (Fig. 2 b) . This result contrasts with that reported by Noteborn et al. (1992) in which S~ nuclease protection analysis located the 3' end of the major transcript 25 nt downstream from the poly(A) addition signal.
To investigate the nature of the 2"0 kb transcript, Northern blot analysis was performed using a series of DNA probes spanning the entire CAV genome. Fragments of approximately 200 to 300 bp, produced by cleavage of the recombinant plasmid pCAV14 with a range of restriction endonucleases, were isolated from low melting point agarose (Gibco-BRL) and labelled with 32p (Feinberg & Vogelstein, 1983) . The probes were then hybridized to Northern blot strips containing total RNA which had been extracted from infected cells ( support the view that the major 2-0 kb transcript is an unspliced message (Noteborn et al., 1992) , Although sequence analysis suggests promoter activity is associated with the CAV non-transcribed region, and the region is rich in sequences of putative regulatory significance, no evidence of promoter activity has yet been demonstrated.
To investigate this further the non-coding region corresponding to positions 2190 to 386 on the circular ssDNA genome (Meehan et al., 1992) was amplified by PCR (94 °C for 1 min; 60 °C for 2 min; 72 °C for 3 min) using the primers 315 (5' GAACAGCACAAGCTTCT-GGGGGACGCAGCC 3') and 316 (5' CGCCGTTCC-CGGATCCCCACCCGGACCGCC 3') containing artificial HindIII and B a m H I recognition sequences respectively. Following restriction endonuclease digestion this PCR product was ligated into the HindIII and B a m H I sites of the human growth hormone (hGH) transient gene expression vector p0GH (Allegro, hGH transient gene expression assay system; Nichols Institute Diagnostics) as described by Selden et al. (1986) . The tandem array of four 19 bp repeats present in the non-transcribed region of the CAV genome, which was thought to be characteristic of an enhancer (Meehan et al., 1992) , was investigated further by the removal of the first pair of 19 bp repeats (positions 157 to 226) by in vitro mutagenesis using the primer 306 (5' CAACGAG-TGGAGCACAAAGAGGCGTTCCCG 3'). In vitro mutagenesis was carried out using the Muta-Gene (BioRad) M13-based system as described by the manufacturer. Clones containing the entire CAV non-coding region lacking the first pair of 19 bp repeats were characterized by DNA sequencing, subjected to PCR using the primers 315 and 316 and subcloned into the p0GH transient gene expression vector. The constructs containing the entire CAV non-coding region (pCAVGH1) and the non-coding region with the first two 19bp repeats deleted (pCAVGH2) allow the monitoring of hGH expression arising as a result of promoter activity associated with the CAV non-coding region, and the effect of deletions made within this region, following transfection.
Confluent COS-7 monolayers (75 cm 2) were cotransfected as described by Sompayrac & Danna (1981) using 20 ~tg of either pCAVGH1 or pCAVGH2 in addition to 20 lag of a cytomegalovirus-fl-galactosidase construct (kindly supplied by Dr H. Brady, MRC, Mill Hill, U.K.), allowing the transfection efficiency to be estimated. At 72 h after transfection the medium was removed, stored at -2 0 °C, and the cell monolayer was disrupted by freezing and thawing in 2 ml of assay buffer (50 mMpotassium phosphate, 1 mi-magnesium chloride, pH 7.5).
The concentration of hGH in duplicate 100 gl aliquots of the respective media was determined using the Tandem hGH solid phase, two-site immunoradiometric assay (Hybritec) in accordance with the manufacturer's instructions. The concentration of fl-galactosidase in duplicate 100 gl aliquots of the respective disrupted cell lysates was estimated using the chromogenic substrate chlorophenol red fl-D-galactopyranoside (Boehringer Mannheim) as described by Simon & Lis (1987) . In addition, total protein estimations were carried out on duplicate 10 gl samples of the respective disrupted cell lysates using a Bradford-based assay (Bio-Rad) allowing the hGH levels in the samples to be expressed in ng/ml after standardizing for transfection efficiency.
Promoter activity associated with the entire CAV noncoding region (pCAVGH1) elicited levels of hGH expression corresponding to 6 to 8 ng/ml. However this level of promoter activity was reduced by 40 to 50% following transfection with the construct pCAVGH2, which lacked the first two 19 bp repeat elements present in the CAV non-coding region. These results provide the first demonstration of promoter activity associated with the non-coding region of the CAV genome and, in addition, highlight the importance of the tandem array of four 19 bp repeats, thought to be an enhancer ( 
